EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY-NC-ND 4.0

Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial

Zhengshan Hong, Wenna Zhang iD, Xin Cai, Zhan Yu, Jiayao Sun, Weiwei Wang, Lienchun Lin, Jingfang Zhao, Jingyi Cheng, Guangyuan Zhang, Qing Zhang, Guoliang Jiang und 1 weitere

Cancer Science · 2023-03 · 114 (3) · 976-983

DOI: 10.1111/cas.15633 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Cancer Science, online erschienen am 15.11.2022. Verfasst von Zhengshan Hong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Heavy Ion Radiotherapy, Radiation Injuries. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluates the feasibility of the pencil beam scanning technique of carbon ion radiotherapy (CIRT) in the setting of hepatocellular carcinoma (HCC) and establishes the maximum tolerated dose (MTD) calculated by the Local Effect Model version I (LEM‐I) with a dose escalation plan. The escalated relative biological effectiveness‐weighted dose levels included 55, 60, 65, and 70 Gy in 10 fractions. Active motion management techniques were employed, and several measures were applied to mitigate the interplay effect induced by a moving target. CIRT was planned with the LEM‐I‐based treatment planning system and delivered by raster scanning. Offline PET/CT imaging was used to verify the beam range. Offline adaptive replanning was performed whenever required. Twenty‐three patients with a median tumor size of 4.3 cm (range, 1.7–8.5 cm) were enrolled in the present study. The median follow‐up time was 56.1 months (range, 5.7–74.4 months). No dose limiting toxicity was observed until 70 Gy, and MTD had not been reached. No patients experienced radiation‐induced liver disease within 6 months after the completion of CIRT. The overall survival rates at 1, 3, and 5 years were 91.3%, 81.9%, and 67.1% after CIRT, respectively. The local progression‐free survival and progression‐free survival rates at 1, 3 and 5 years were 100%, 94.4%, and 94.4% and 73.6%, 59.2%, and 37.0%, respectively. The raster scanning technique could be used to treat HCC. However, caution should be exercised to mitigate the interplay effect. CIRT up to 70 Gy in 10 fractions over 2 weeks was safe and effective for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHeavy Ion RadiotherapyRadiation InjuriesHumansPositron Emission Tomography Computed TomographyRadiotherapy Dosage

Stichwörter der Autor:innen

carbon ion radiotherapydose escalationhepatocellular carcinomapencil beam scanningphase I trial

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Shanghai, China.
  • Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
  • Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
  • Department of Medical Physics, Shanghai Proton and Heavy Ion Center, Shanghai, China.
  • Department of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
  • Department of Radiology, Shanghai Proton and Heavy Ion Center, Shanghai, China.

ORCID-Profile: Wenna Zhang

Zitieren

APA

Hong, Z., Zhang, W., Cai, X., Yu, Z., Sun, J., Wang, W., Lin, L., Zhao, J., Cheng, J., Zhang, G., Zhang, Q., Jiang, G., & Wang, Z. (2023). Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial. Cancer Science, 114(3), 976-983. https://doi.org/10.1111/cas.15633

Vancouver

Hong Z, Zhang W, Cai X, Yu Z, Sun J, Wang W, et al. Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial. Cancer Science. 2023;114(3):976-983. doi:10.1111/cas.15633

BibTeX
@article{Hong2023,
  author = {Hong, Zhengshan and Zhang, Wenna and Cai, Xin and Yu, Zhan and Sun, Jiayao and Wang, Weiwei and Lin, Lienchun and Zhao, Jingfang and Cheng, Jingyi and Zhang, Guangyuan and Zhang, Qing and Jiang, Guoliang and Wang, Zheng},
  title = {Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long‐term outcomes from a phase I trial},
  journal = {Cancer Science},
  year = {2023},
  volume = {114},
  number = {3},
  pages = {976--983},
  doi = {10.1111/cas.15633}
}
Kostenlos starten →